Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Prevalence of high-risk human papilloma virus among women with hepatitis C virus before liver transplantation.

Tarallo PA, Smolowitz J, Carriero D, Tarallo J, Siegel A, Jia H, Emond JC.

Transpl Infect Dis. 2013 Aug;15(4):400-4. doi: 10.1111/tid.12086. Epub 2013 May 6.

2.

Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.

Le T, Hicks W, Menard C, Boyd D, Hewson T, Hopkins L, Kee Fung MF.

J Obstet Gynaecol Can. 2004 Sep;26(9):788-92.

PMID:
15361273
3.

Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany.

Petry KU, Luyten A, Justus A, Iftner A, Strehlke S, Reinecke-Lüthge A, Grunwald E, Schulze-Rath R, Iftner T.

BMC Infect Dis. 2013 Mar 13;13:135. doi: 10.1186/1471-2334-13-135.

4.

Spectrum of genital human papillomavirus infection in a female adolescent population.

Jamison JH, Kaplan DW, Hamman R, Eagar R, Beach R, Douglas JM Jr.

Sex Transm Dis. 1995 Jul-Aug;22(4):236-43.

PMID:
7482107
5.

Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.

Branca M, Garbuglia AR, Benedetto A, Cappiello T, Leoncini L, Migliore G, Agarossi A, Syrjänen K; DIANAIDS Collaborative Study Group.

Int J STD AIDS. 2003 Jun;14(6):417-25.

PMID:
12816671
6.

Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.

Figueroa JP, Ward E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD.

Sex Transm Dis. 1995 Mar-Apr;22(2):114-8.

PMID:
7624812
7.

Incidence, clearance and predictors of human papillomavirus infection in women.

Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, Sparrow J, Lorincz A; Survey of HPV in Ontario Women Group.

CMAJ. 2003 Feb 18;168(4):421-5.

8.

Risk factors for HPV DNA detection in middle-aged women.

Muñoz N, Kato I, Bosch FX, Eluf-Neto J, De Sanjosé S, Ascunce N, Gili M, Izarzugaza I, Viladiu P, Tormo MJ, Moreo P, Gonzalez LC, Tafur L, Walboomers JM, Shah KV.

Sex Transm Dis. 1996 Nov-Dec;23(6):504-10.

PMID:
8946637
9.

Prevalence and risk factors for human papillomavirus DNA in cervical cytology.

Kasap B, Yetimalar H, Keklik A, Yildiz A, Cukurova K, Soylu F.

Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):168-71. doi: 10.1016/j.ejogrb.2011.06.021. Epub 2011 Jul 18.

PMID:
21764503
10.

Initial prevalence of anal human papilloma virus infection in liver transplant recipients.

Grąt M, Grąt K, Hołówko W, Malejczyk M, Walter de Walthoffen S, Lewandowski Z, Kobryń K, Patkowski W, Majewski S, Młynarczyk G, Krawczyk M.

Transpl Int. 2014 Aug;27(8):816-23. doi: 10.1111/tri.12339. Epub 2014 May 24.

11.

The relationship between contraceptives, sexual practices, and cervical human papillomavirus infection among a college population.

Burkett BJ, Peterson CM, Birch LM, Brennan C, Nuckols ML, Ward BE, Crum CP.

J Clin Epidemiol. 1992 Nov;45(11):1295-302.

PMID:
1331341
12.

Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence.

Frega A, Stentella P, De Ioris A, Piazze JJ, Fambrini M, Marchionni M, Cosmi EV.

Cancer Lett. 2003 Jul 10;196(2):127-34.

PMID:
12860270
13.

Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.

Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA.

JAMA. 1999 May 5;281(17):1605-10.

PMID:
10235153
14.

PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears.

Rozendaal L, Walboomers JM, van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst TJ, van Ballegooijen M, Meijer CJ.

Int J Cancer. 1996 Dec 11;68(6):766-9.

15.

High- and intermediate-risk human papillomavirus infection in sexually active adolescent females.

Lüdicke F, Stalberg A, Vassilakos P, Major AL, Campana A.

J Pediatr Adolesc Gynecol. 2001 Nov;14(4):171-4.

PMID:
11748012
16.

Risk factors for cervical neoplasia in Denmark.

Kjaer SK.

APMIS Suppl. 1998;80:1-41.

PMID:
9693662
17.

Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.

Hankins C, Coutlée F, Lapointe N, Simard P, Tran T, Samson J, Hum L.

CMAJ. 1999 Jan 26;160(2):185-91.

18.

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.

J Natl Cancer Inst. 2003 Jan 1;95(1):46-52.

PMID:
12509400
19.

Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.

Smith LW, Khurshed F, van Niekerk DJ, Krajden M, Greene SB, Hobbs S, Coldman AJ, Franco EL, Ogilvie GS.

BMC Public Health. 2014 Oct 10;14:1060. doi: 10.1186/1471-2458-14-1060.

20.

Prevalence of high-risk cervical human papillomavirus and squamous intraepithelial lesion in Nigeria.

Pimentel VM, Jiang X, Mandavilli S, Umenyi Nwana C, Schnatz PF.

J Low Genit Tract Dis. 2013 Apr;17(2):203-9. doi: 10.1097/LGT.0b013e3182612042.

PMID:
23343701

Supplemental Content

Support Center